Vicarious Surgical to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 17, 2025
Vicarious Surgical (NYSE: RBOT) has scheduled its Fourth Quarter and Fiscal Year 2024 financial results announcement for March 17, 2025, after market close. The robotics technology company, focused on advancing robotic surgery, will host a conference call at 4:30 p.m. Eastern Time to discuss the results.
Investors can participate in the conference call by dialing +1 833-470-1428 (domestic) or +1 404-975-4839 (international) with access code 373279. A webcast will be available live and archived at the company's investor relations website.
Vicarious Surgical (NYSE: RBOT) ha programmato l'annuncio dei risultati finanziari per il Quarto Trimestre e l'Anno Fiscale 2024 per il 17 marzo 2025, dopo la chiusura del mercato. L'azienda di tecnologia robotica, focalizzata sull'avanzamento della chirurgia robotica, ospiterà una conferenza telefonica alle 16:30, ora orientale, per discutere i risultati.
Gli investitori possono partecipare alla conferenza telefonica componendo il numero +1 833-470-1428 (nazionale) o +1 404-975-4839 (internazionale) con il codice di accesso 373279. Sarà disponibile un webcast in diretta e archiviato sul sito web delle relazioni con gli investitori dell'azienda.
Vicarious Surgical (NYSE: RBOT) ha programado el anuncio de sus resultados financieros del Cuarto Trimestre y Año Fiscal 2024 para el 17 de marzo de 2025, después del cierre del mercado. La empresa de tecnología robótica, centrada en avanzar en la cirugía robótica, llevará a cabo una conferencia telefónica a las 4:30 p.m. hora del Este para discutir los resultados.
Los inversores pueden participar en la conferencia telefónica marcando +1 833-470-1428 (nacional) o +1 404-975-4839 (internacional) con el código de acceso 373279. Habrá una transmisión en vivo y una grabación disponible en el sitio web de relaciones con inversores de la empresa.
Vicarious Surgical (NYSE: RBOT)는 2024 회계연도 4분기 재무 결과 발표를 2025년 3월 17일 시장 종료 후에 예정하고 있습니다. 로봇 수술을 발전시키는 데 집중하는 로봇 기술 회사는 결과를 논의하기 위해 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜을 주최할 예정입니다.
투자자는 +1 833-470-1428(국내) 또는 +1 404-975-4839(국제)로 전화하여 액세스 코드 373279를 입력하여 컨퍼런스 콜에 참여할 수 있습니다. 회사의 투자자 관계 웹사이트에서 생중계 및 아카이브된 웹캐스트를 이용할 수 있습니다.
Vicarious Surgical (NYSE: RBOT) a prévu l'annonce de ses résultats financiers pour le quatrième trimestre et l'exercice 2024 pour le 17 mars 2025, après la fermeture du marché. L'entreprise de technologie robotique, axée sur l'avancement de la chirurgie robotique, organisera une conférence téléphonique à 16h30, heure de l'Est, pour discuter des résultats.
Les investisseurs peuvent participer à la conférence téléphonique en composant le +1 833-470-1428 (national) ou le +1 404-975-4839 (international) avec le code d'accès 373279. Un webcast sera disponible en direct et archivé sur le site Web des relations avec les investisseurs de l'entreprise.
Vicarious Surgical (NYSE: RBOT) hat die Bekanntgabe der finanziellen Ergebnisse für das 4. Quartal und das Geschäftsjahr 2024 für den 17. März 2025, nach Börsenschluss, angesetzt. Das Robotik-Technologieunternehmen, das sich auf die Weiterentwicklung der robotergestützten Chirurgie konzentriert, wird um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Investoren können an der Telefonkonferenz teilnehmen, indem sie +1 833-470-1428 (national) oder +1 404-975-4839 (international) mit dem Zugangscode 373279 anrufen. Ein Webcast wird live verfügbar sein und auf der Website der Investor Relations des Unternehmens archiviert.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 373279. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com.
About Vicarious Surgical
Founded in 2014, Vicarious Surgical is a next generation surgical robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250303031449/en/
Investor
Kaitlyn Brosco
Vicarious Surgical
Kbrosco@vicarioussurgical.com
Media Inquiries
media@vicarioussurgical.com
Source: Vicarious Surgical Inc.
FAQ
When will Vicarious Surgical (RBOT) release Q4 and FY 2024 earnings?
How can investors join RBOT's Q4 2024 earnings call?
Where can I access the webcast for RBOT's Q4 2024 earnings?
What time is Vicarious Surgical's (RBOT) Q4 2024 earnings call?
